Briefing: Binding to RNA is not enough—changing its shape is what makes a drug work, study reveals

The study, published on March 29, 2026, underscores the significance of RNA shape in drug design, suggesting that mere binding is insufficient for therapeutic effectiveness.

RNAs function as messengers in the cellular machinery, linking DNA to protein synthesis while also playing vital regulatory roles in various biological processes.

This research opens new avenues for drug development, indicating that targeting RNA's structural conformation could enhance the efficacy of treatments.